Frank U Reuss

Title: Frank U Reuss: Innovator in Hybrid Live Vaccines

Introduction

Frank U Reuss is a notable inventor based in Alzenau, Germany. He has made significant contributions to the field of genetic engineering, particularly in the development of hybrid live vaccines. His innovative approach has the potential to enhance immune responses against various pathogens.

Latest Patents

Frank U Reuss holds a patent for a "Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines." This invention relates to a genetic engineering process that optimizes the production and exposure of additional antigens coded for by a live vaccine. The process utilizes spontaneous DNA reorganization in the recombinant live vaccine, resulting in two subpopulations. Subpopulation A is capable of infecting and acts immunogenically, while subpopulation B is regenerated by A, producing additional antigens and acting immunogenically with respect to these antigens. This dual subpopulation formation ensures that the infection process necessary for inducing an immune response occurs without disturbing the formation of additional antigens.

Career Highlights

Frank U Reuss is affiliated with the Max Planck Society for the Advancement of Science, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in vaccine development and immunology.

Collaborations

Some of his notable coworkers include Thomas F Meyer and Johannes Pohlner. Their collaborative efforts have further advanced the research and development of hybrid live vaccines.

Conclusion

Frank U Reuss is a pioneering inventor whose work in hybrid live vaccines exemplifies the intersection of genetic engineering and immunology. His contributions are poised to make a significant impact on vaccine technology and public health.